Bank of New York Mellon »

Atrium Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2026-03-31 $584k 44k 13.37

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Inc-cl C Cap (GOOG)
Meta Platforms Inc-class A Cl A (META)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Johnson & Johnson (JNJ)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Eli Lilly & Co. (LLY)

View all positions for Bank of New York Mellon

Top funds holding Atrium Therapeutics

BlackRock
Susquehanna International
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Farallon Capital Management
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Bellevue Group
State Street Corporation
Weiss Asset Management LP[1

View all funds holding Atrium Therapeutics